NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Stem Cell
Therapies in Neurology
Summary
"Stem Cell Therapies in Neurology", is an evolving field. The
current pipeline of products feature different types of stem cells
and these therapies have the potential to target a range of
neurological diseases. However, there are challenges associated
with the development of these therapies, including the need to
demonstrate strong safety and efficacy data.
Read the full report: https://www.reportlinker.com/p05588761
Biotechnology companies currently dominate in this field and are
expected to lead the development of different pipeline
products.
The current pipeline consists of 16 products (Phase 1,2, and 3),
and the most common indications for which these products are being
evaluated include Amyotrophic Lateral Sclerosis (ALS), Alzheimer's
Disease and Parkinson's Disease. The most commonly understood
mechanism of action underlying stem cells therapy in neurology is
the potential ability of these therapies to secrete trophic factors
that help in neuronal survival and growth.
As research in this field progresses, it is expected to help
further improve the understanding of how these therapies work and,
potentially address unmet needs in the field of neurology.
Key Questions Answered
- What are the key unmet needs clinically and in research? What do
KOLs identify as the key unmet needs? Will the products in the stem
cells pipeline fill these unmet needs?
- When are the pipeline products expected to launch? What are the
key features of the products in the pipeline?
- What are some of the factors that need to be considered for
market access of these products?
- What are the challenges associated with development of stem cell
therapies in neurology?
- What are the regulatory frameworks in the 8MM that oversee the
development of stem cell therapies?
Scope
- Overview of Stem Cells and Epidemiology: focuses on different
types of stem cells for neurology, factors to be considered when
deciding a stem cell strategy, and epidemiology of different
neurological diseases.
- Regulatory Oversight: focuses on regulatory agencies in the 8MM
(US, France, Germany, Italy, Spain,
UK, China, Japan).
- Clinical Trials and Key Developers: overview of ongoing clinical
trials, mapping of clinical trials, and challenges of conducting
clinical trials for stem cells in neurology.
- Pipeline Analysis: comprehensive data assessing emerging products
and mechanisms of action under development for stem cells therapy
in neurology. The most promising candidate in Phase III (and Phase
II/III) development is profiled.
- Market Access and Market Outlook: factors affecting the access of
these therapies, along with focus on unmet needs in neurology which
can be potentially addressed by stem cell therapies. Market
potential for some of the pipeline drugs are also addressed along
with anticipated key events.
Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies
through a review of pipeline products and technologies, and by
identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping
and driving the stem cells market for neurology.
- Drive revenues by understanding the key trends, innovative
products and technologies, market segments, and companies likely to
impact the neurology stem cells market in the future.
- Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analysing the
performance of various competitors.
- Identify emerging players with potentially strong product
portfolios and create effective counter-strategies to gain a
competitive advantage.
- Organize your sales and marketing efforts by identifying the
market categories and segments that present maximum opportunities
for consolidations, investments and strategic partnerships.
Read the full report: https://www.reportlinker.com/p05588761
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/stem-cell-therapies-in-neurology-300733081.html
SOURCE Reportlinker